Point of Care Diagnostics Market is Prophesied to Reach US$ 66 Billion by the end of 2028

According to this new report, point of care test (POCT) kit shipments are anticipated to soar at a CAGR of almost 7% between 2021 and 2028. The global point of care diagnostics market had a value of $34.1 billion in 2020 and is projected to grow to $66 billion by the end of 2028.

In the upcoming years, point of care diagnostics will generate more money due to the rising global popularity of rapid testing kits. Demand for rapid testing kits has increased as a result of the significant rise in the prevalence of chronic diseases around the world. These kits allow for quicker diagnosis and increase the likelihood that patients will respond favorably to treatment.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7266?AS

𝗞𝗲𝘆 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗣𝗿𝗼𝗳𝗶𝗹𝗲𝗱:

• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson Services Inc.
• bioMérieux SA
• Nova Biomedical
• Siemens AG
• Danaher Corporation
• Cardinal Health Inc.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc.
• BD
• Abbott

𝗞𝗲𝘆 𝗦𝘁𝗮𝘁𝗶𝘀𝘁𝗶𝗰𝘀 𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗦𝘂𝗿𝗴𝗲

• Increasing demand: The point-of-care diagnostics market is experiencing significant growth due to the increasing demand for rapid and convenient diagnostic testing. Point-of-care diagnostics offer on-the-spot testing and quick results, eliminating the need for laboratory-based testing and reducing turnaround time for diagnosis and treatment.
• Technological advancements: The market is driven by continuous technological advancements in point-of-care diagnostic devices. Innovations such as miniaturization, biosensors, smartphone connectivity, and improved testing methods have enhanced the accuracy, sensitivity, and usability of point-of-care diagnostic devices, making them more reliable and accessible.
• Infectious disease testing: Point-of-care diagnostics play a crucial role in the rapid and accurate detection of infectious diseases, such as HIV, influenza, malaria, and COVID-19. These tests enable early detection, timely treatment, and effective disease management, particularly in resource-limited settings where access to laboratory infrastructure is limited.
• Chronic disease management: Point-of-care diagnostics are increasingly used in the management of chronic diseases, such as diabetes, cardiovascular conditions, and respiratory disorders. These tests enable patients to monitor their health status at home or in community healthcare settings, facilitating timely intervention, medication adjustment, and disease control.
• Convenience and accessibility: Point-of-care diagnostics offer convenience and accessibility by bringing diagnostic testing closer to patients. They can be used in various healthcare settings, including hospitals, clinics, ambulatory care centers, and home care settings, allowing for immediate testing and decision-making without the need for sample transportation or laboratory processing.

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲:

Key point of care diagnostic solution providers are focusing on mergers and acquisitions to increase their market presence on a global scale and are also aiming to fast track product development and research with these efforts.

• In September 2021, a next-generation point of care diagnostic solution provider - LumiraDx Limited - announced the completion of a merger agreement that was previously discussed with CA Healthcare Acquisition Corp., which is a special purpose acquisition entity based in the United States.

𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

• 𝗕𝘆 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺:

o Lateral Flow Assays-based POC Tests
o Dipsticks POC
o Microfluidic Point of Care Testing
o Molecular Diagnostics
o Immunoassay Technology
o Others

• 𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻:

o Glucose Monitoring Products
o Cardiometabolic Monitoring Products
o Infectious Disease Testing Products
o Pregnancy & Fertility Testing Products
o Urinalysis Testing Products
o Cholesterol Testing Products
o Hematology Testing Products
o Drugs-of-abuse Testing Products
o Others

• 𝗕𝘆 𝗘𝗻𝗱 𝗨𝘀𝗲𝗿:

o Hospitals
o Diagnostic Laboratories
o Clinics/Physician Offices
o Home Care
o Others

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗙𝗼𝗿 𝗣𝗼𝗶𝗻𝘁 𝗼𝗳 𝗖𝗮𝗿𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗠𝗮𝗿𝗸𝗲𝘁:

• APAC (Japan, China, South Korea, Australia, India, and the rest of APAC; the rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (USA, Canada and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, United Arab Emirates, South Africa)

𝗞𝗲𝘆 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝘁𝗵𝗲 𝗣𝗼𝗶𝗻𝘁 𝗼𝗳 𝗖𝗮𝗿𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁

• What is the projected value of the Point of Care Diagnostics factors Industry in 2023?
• At what rate will the global Point of Care Diagnostics factors market size grow until 2033?
• Which are the factors hampering the growth of Point of Care Diagnostics factors?
• Which region is expected to lead in the global Point of Care Diagnostics factors market By 2033?
• Which are the factors driving the Point of Care Diagnostics factors Industry during the forecast period?
• What is the expected market value of the Point of Care Diagnostics factors market during the forecast period?

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7266?AS

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : sales@factmr.com

𝗔𝗯𝗼𝘂𝘁 𝗙𝗮𝗰𝘁.𝗠𝗥

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That's why focus on offering insights that can actually make a difference to bottom-lines.

This release was published on openPR.